Association of overweight/obesity and overweight/obesity-related metabolic dysfunction-associated steatotic liver disease in young adults with coronary artery calcification later in life

被引:2
|
作者
Wang, Jia-Jie [1 ]
Zheng, Zhichao [1 ]
Zhang, Ying [1 ]
机构
[1] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Cardiol, 106 Zhongshan 2nd Rd, Guangzhou 510080, Peoples R China
来源
DIABETES OBESITY & METABOLISM | 2024年 / 26卷 / 09期
关键词
CAC; MASLD; obesity; overweight; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; RISK DEVELOPMENT; UNITED-STATES; WEIGHT-LOSS; OBESITY; PREVALENCE; NUTRITION; ADOLESCENTS; MANAGEMENT;
D O I
10.1111/dom.15733
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimThe association of overweight/obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) in young adulthood with subclinical atherosclerosis [coronary artery calcification (CAC) and abdominal aortic calcification (AAC)] by middle age is unknown.MethodIn total, 2274 participants aged 28-39 years from the coronary artery risk development in young adults study at year 10 (1995-1996) who were re-examined 15 years later were included. CAC and AAC were measured at year 25 using computed tomography. We examined the utility of three young adult phenotypes (lean group; overweight/obese group; overweight/obese MASLD group) at year 10 in predicting CAC or AAC by middle age. Modified Poisson regression was used to estimate the association between groups and CAC, and AAC. Independent determinates of CAC and AAC were determined with linear regression models.ResultsCompared with individuals categorized as lean in young adulthood, the relative risk for CAC by middle age was 1.09 (95% confidence interval: 0.93-1.28) for those with overweight/obesity and 1.32 (95% confidence interval: 1.08-1.61) for those with overweight/obesity-related MASLD. For AAC, no difference was observed between these three groups. Group, systolic blood pressure and group x systolic blood pressure interaction were all the independent determinates for CAC.ConclusionIn this study, young adults with overweight/obesity-related MASLD have a higher risk of developing CAC by middle age. These abnormalities are only partially explained by traditional cardiovascular risk factors, and overweight/obesity-related MASLD has an independent impact on CAC. Our study provides evidence for identifying young adults at higher risk of developing subclinical atherosclerosis.
引用
收藏
页码:3860 / 3867
页数:8
相关论文
共 50 条
  • [1] Visceral Obesity and Its Association with Severe Coronary Artery Calcification in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kang, Min Kyu
    Song, Jeung Eun
    Kweon, Young Oh
    Tak, Won Young
    Park, Soo Young
    Lee, Yu Rim
    Park, Jung Gil
    DIAGNOSTICS, 2024, 14 (20)
  • [2] SOCIAL DETERMINANTS OF HEALTH AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IN CHILDREN WITH OVERWEIGHT OR OBESITY
    Venkatesh, Ananya
    Thai, Nhat
    Nicalo, Patricia Ugalde
    Newton, Kimberly
    Behling, Cynthia
    Ignacio, Romeo
    Bauman, Laura
    Smith, Martha
    Schwimmer, Jeffrey
    HEPATOLOGY, 2024, 80 : S712 - S713
  • [3] Mechanobiology in Metabolic Dysfunction-Associated Steatotic Liver Disease and Obesity
    Rudolph, Emily L.
    Chin, LiKang
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (07) : 7134 - 7146
  • [4] Metabolomic Hallmarks of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Beyoglu, Diren
    Popov, Yury V.
    Idle, Jeffrey R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [5] Modelling and assessment of glucose-lactate kinetics in youth with overweight, obesity and metabolic dysfunction-associated steatotic liver disease: A pilot study
    Bonet, Jacopo
    Fox, Delaney
    Nelson, Rafaela
    Nelson, Michael B.
    Nelson, Loretta
    Fernandez, Cristina
    Barbieri, Emiliano
    Dalla Man, Chiara
    Santoro, Nicola
    DIABETES OBESITY & METABOLISM, 2024, 26 (08): : 3207 - 3212
  • [6] Incidence of metabolic dysfunction-associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study
    Kim, Kunhee
    Lee, Yaeji
    Lee, Jae Seung
    Kim, Mi Na
    Kim, Beom Kyung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Jung, Inkyung
    Lee, Hye Won
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (12) : 2845 - 2852
  • [7] Liver tissue lipids in metabolic dysfunction-associated steatotic liver disease with diabetes and obesity
    Sourianarayanane, Achuthan
    Brydges, Christopher R.
    McCullough, Arthur J.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (07)
  • [8] Metabolic dysfunction-associated steatotic liver disease in adults
    Huang, Daniel Q.
    Wong, Vincent W. S.
    Rinella, Mary E.
    Boursier, Jerome
    Lazarus, Jeffrey V.
    Yki-Jarvinen, Hannele
    Loomba, Rohit
    NATURE REVIEWS DISEASE PRIMERS, 2025, 11 (01):
  • [9] Metabolic profiling of tryptophan pathways: Implications for obesity and metabolic dysfunction-associated steatotic liver disease
    Arto, Carmen
    Rusu, Elena Cristina
    Clavero-Mestres, Helena
    Barrientos-Riosalido, Andrea
    Bertran, Laia
    Mahmoudian, Razieh
    Aguilar, Carmen
    Riesco, David
    Chicote, Javier Ugarte
    Parada, David
    Martinez, Salome
    Sabench, Fatima
    Richart, Cristobal
    Auguet, Teresa
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (11)
  • [10] The potential role of omentin-1 in obesity-related metabolic dysfunction-associated steatotic liver disease: evidence from translational studies
    Noel Salvoza
    Pablo Giraudi
    Silvia Gazzin
    Deborah Bonazza
    Silvia Palmisano
    Nicolò de Manzini
    Fabrizio Zanconati
    Alan Raseni
    Francesca Sirianni
    Claudio Tiribelli
    Natalia Rosso
    Journal of Translational Medicine, 21